Skip to content
Back to results

Multivitamin supplements

Combination vitamin and mineral tablets taken routinely, usually without a diagnosed deficiency.

At a glance

  • Evidence: COSMOS found small cognitive-test benefits in older adults.Cognitive test performance in older adults · Limited certainty · Randomized intervention
  • What’s uncertain: One trial programme does not establish dementia prevention or longer life.
  • First step: Review nutrient adequacy, medicines and reasons for taking a multivitamin.
  • Before you try it: Check overlapping nutrients and interactions, especially with anticoagulants. All precautions

Takeaway

The COSMOS cognitive substudies found small improvements in global cognition and episodic memory in older adults. They come from one parent trial programme and do not establish dementia prevention or benefit in every age group. A separate COSMOS analysis found small changes in two epigenetic clocks, with no effect on three others; clinical meaning and longevity remain unproven. A tested multivitamin formulation cannot establish equivalent benefit from every product, and nutrient-specific treatment remains a separate decision.

NutritionLong-term healthUnder 10 min · Easy · Low
Reviewed Oct 3, 2026
Save

Scientific evidence

What the research shows

Outcome assessments based on research, including its uncertainties and limitations.

Cognitive test performance in older adults

Finding: Benefit supportedCertainty: Limitedstudies found a benefit from doing this

Evidence basis: randomised trials

COSMOS found small average cognitive-test benefits in older adults.

Population: Adults aged at least 60 years in one parent randomized trial, with three separate cognitive substudies.

Research details

Summary

The meta-analysis of three nonoverlapping COSMOS substudies found a global-cognition difference of 0.07 SD units (95% CI 0.03 to 0.11) and episodic memory of 0.06 SD units (95% CI 0.03 to 0.10). The clinic substudy did not show a significant executive-function/attention benefit. These are test-score changes, not measured prevention of dementia.

Why this certainty

Limited because randomized results are promising but concentrated within one trial programme, with small effects and outcome-specific differences.

Limitations

Substudies share a trial programme and formulation; independent replication is needed. Small average effects and two-year testing do not establish prevention of clinical dementia or generalization to younger adults.

Effect estimate

Global cognition: 0.07 SD units (95% CI 0.03 to 0.11); episodic memory: 0.06 SD units (95% CI 0.03 to 0.10).

Epigenetic-clock changes and clinical longevity

Finding: Insufficient direct evidenceCertainty: Very limitedthis has not been directly tested

Evidence basis: indirect evidence, not a direct test of this exact habit

Small epigenetic-clock changes do not establish slower clinical aging or longer life.

Population: 958 older COSMOS participants in an ancillary randomized analysis.

Research details

Summary

A prespecified two-year COSMOS analysis in 958 people found small differences in PCGrimAge and PCPhenoAge, while the other three assessed clocks did not show a multivitamin effect. The investigators state that clinical relevance needs further study. No increase in lifespan was demonstrated by this clock analysis.

Why this certainty

Very limited for longevity because the cited trial measures biomarker changes, not lifespan or a validated clinical aging benefit.

Limitations

DNA-methylation clocks are surrogate measures and different clocks can disagree. Multiple measures, one formulation and short follow-up limit claims about clinical aging.

What people say

Who discusses this?

Public statements, with positions specific to each source and topic. These views do not determine the scientific evidence assessment.

What the research shows ↑

Practical steps and precautions

How to try it

  1. Review nutrient adequacy, medicines and reasons for use before deciding whether a multivitamin is relevant to you.
  2. If cognition is the goal, recognize that the direct positive findings concern older adults and a defined trial formulation, not all ages or all products.
  3. Check labels for overlapping vitamins and minerals and consider independent product-quality testing; a quality seal does not establish clinical effectiveness.
  4. Keep a varied food pattern and established medical care; do not use an epigenetic-clock marketing claim as proof that a product extends life.

Precautions

  • High doses of some vitamins and minerals are harmful, particularly vitamin A and iron.
  • Some supplements interact with prescribed medicines, including anticoagulants.

References

Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS.

Vyas CM, Manson JE, Sesso HD, Cook NR, Rist PM, Weinberg A, Moorthy MV, Baker LD, Espeland MA, Yeung LK, Brickman AM, Okereke OI. · The American journal of clinical nutrition · 2024

Systematic reviewCOSMOS-Clinic randomized trial and meta-analysis of three nonoverlapping cognitive substudies within the same parent trialVerified from abstract
Open original source

Effects of daily multivitamin-multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial.

Li S, Hamaya R, Zhu H, Chen BH, Pereira AC, Ivey KL, Rist PM, Manson JE, Dong Y, Sesso HD. · Nature medicine · 2026

Prespecified two-year ancillary randomized trial analysis in 958 older adultsVerified from abstract
Open original source

Community

Discussion

Have you tried this? What helped or made it difficult?

Reader experiences are separate from the scientific evidence. Explore all discussions

No discussions yet.

Be the first to ask a question or share your experience.

Sign in to vote or join the discussion.

Explore other habits in a shared category. Each has its own evidence and precautions.

Editorial history and review method

Revision 4 · Approved for publication · Codex (publication approval explicitly authorized by site owner; category migration)

Prepared and checked with AI. Publication approval does not imply independent expert review. Request a correction.

Evidence semantics migrated: findings now describe doing the habit, evidence basis is explicit, and the catalogue card uses an editorially selected claim. Basic coverage: contains no outcome claims; deficiency treatment explicitly left to clinical care. October 3 video follow-up: Upgraded Basic to Standard with two narrowly defined assessments: small older-adult cognitive-test benefits and insufficient direct longevity evidence from epigenetic clocks. Check independent replication, formulation matching, the clinic confidence intervals and all five clock results before approval. Publication release 2026-10-04: site owner authorized a bounded AI audit and release of this exact revision. See docs/release-audit-2026-10-04.md for source-check findings and limits. No independent health-professional or peer review is claimed. Category migration 2026-10-04: removed the separate goals field; categories: Nutrition → Nutrition, Long-term health. Research assessments, sources, guidance, precautions, and evidence review dates are unchanged. This revision awaits publication approval; no new evidence review is claimed. Publication approval 2026-10-04: site owner explicitly accepted all current category-migration revisions for deployment and requested that remaining limitations be retained in docs/content-review-backlog.md. Approval applies to this exact content revision. No new evidence review, independent expert review, or clinical validation is claimed; existing precautions and disclosures remain in effect.